Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties
暂无分享,去创建一个
Jun Wang | Olga Genilloud | Oscar Salazar | Sang Ho Lee | Francisca Vicente | Katherine Young | D. Cully | F. Vicente | R. Cummings | Ó. Salazar | L. Hernandez | O. Genilloud | M. Motyl | R. Painter | A. Basilio | F. Peláez | Andrew M. Galgoci | Sheo B Singh | Fernando Pelaez | Hiranthi Jayasuriya | Kithsiri Herath | Srinivas Kodali | Andrew Galgoci | Ronald Painter | Angela Basilio | Sheo B. Singh | Steven L Colletti | S. Colletti | K. Young | K. Herath | F. Racine | Karen Dorso | Richard Cummings | Mary Motyl | Lorraine Hernandez | Fred Racine | Elizabeth Tinney | Ignacio González | Doris F Cully | H. Jayasuriya | S. H. Lee | Jun Wang | Elizabeth Tinney | S. Kodali | K. Dorso | Ignacio González
[1] Jie J. Zheng,et al. The structural biology of type II fatty acid biosynthesis. , 2005, Annual review of biochemistry.
[2] C. Rock,et al. Overproduction of beta-ketoacyl-acyl carrier protein synthase I imparts thiolactomycin resistance to Escherichia coli K-12 , 1992, Journal of bacteriology.
[3] R J Heath,et al. Lipid biosynthesis as a target for antibacterial agents. , 2001, Progress in lipid research.
[4] O. Sebek,et al. Isolation and structure of antibiotic U-68,204, a new thiolactone. , 1986, The Journal of antibiotics.
[5] Sheo B Singh,et al. Empirical antibacterial drug discovery--foundation in natural products. , 2006, Biochemical pharmacology.
[6] S. Ōmura,et al. Thiotetromycin, a new antibiotic. Taxonomy, production, isolation, and physicochemical and biological properties. , 1983, The Journal of antibiotics.
[7] J. Balkovec,et al. Increased antifungal activity of L-733,560, a water-soluble, semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis , 1994, Antimicrobial Agents and Chemotherapy.
[8] S. Ehrlich,et al. Essential Bacillus subtilis genes , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[9] Andrzej Witkowski,et al. Structural and functional organization of the animal fatty acid synthase. , 2003, Progress in lipid research.
[10] L. Silver,et al. Multi-targeting by monotherapeutic antibacterials , 2007, Nature Reviews Drug Discovery.
[11] Xiayang Qiu,et al. First X-ray cocrystal structure of a bacterial FabH condensing enzyme and a small molecule inhibitor achieved using rational design and homology modeling. , 2003, Journal of medicinal chemistry.
[12] J. Cronan,et al. β-Ketoacyl-Acyl Carrier Protein Synthase III (FabH) Is Essential for Bacterial Fatty Acid Synthesis* , 2003, Journal of Biological Chemistry.
[13] L. Silver,et al. Leakage of periplasmic enzymes from envA1 strains of Escherichia coli , 1991, Journal of bacteriology.
[14] A. Matsumae,et al. STUDIES ON CERULENIN. IV. BIOLOGICAL CHARACTERISTICS OF CERULENIN. , 1964, The Journal of antibiotics.
[15] R. Heath,et al. Fatty acid biosynthesis as a target for novel antibacterials. , 2004, Current opinion in investigational drugs.
[16] D. Schmatz,et al. Determination of Selectivity and Efficacy of Fatty Acid Synthesis Inhibitors* , 2005, Journal of Biological Chemistry.
[17] Jun Wang,et al. Discovery of FabH/FabF Inhibitors from Natural Products , 2006, Antimicrobial Agents and Chemotherapy.
[18] Martin Rosenberg,et al. Identification of Critical Staphylococcal Genes Using Conditional Phenotypes Generated by Antisense RNA , 2001, Science.
[19] R. Heath,et al. Inhibition of β-Ketoacyl-Acyl Carrier Protein Synthases by Thiolactomycin and Cerulenin , 2001, The Journal of Biological Chemistry.
[20] R. Heath,et al. Broad Spectrum Antimicrobial Biocides Target the FabI Component of Fatty Acid Synthesis* , 1998, The Journal of Biological Chemistry.
[21] J. Mekalanos,et al. A genome-scale analysis for identification of genes required for growth or survival of Haemophilus influenzae , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[22] C. Rock,et al. The application of computational methods to explore the diversity and structure of bacterial fatty acid synthase Published, JLR Papers in Press, November 4, 2002. DOI 10.1194/jlr.R200016-JLR200 , 2003, Journal of Lipid Research.
[23] W. Jacobs,et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. , 1994, Science.
[24] D. Hopwood,et al. β-Ketoacyl Acyl Carrier Protein Synthase III (FabH) Is Essential for Fatty Acid Biosynthesis in Streptomyces coelicolor A3(2) , 2001 .
[25] S. Kauppinen,et al. β-ketoacyl-ACP synthase I of Escherichia coli: Nucleotide sequence of thefabB gene and identification of the cerulenin binding residue , 1988, Carlsberg research communications.
[26] C. Rock,et al. Response of Bacillus subtilis to Cerulenin and Acquisition of Resistance , 2001, Journal of bacteriology.
[27] H. Okazaki,et al. Thiolactomycin, a new antibiotic. III. In vitro antibacterial activity. , 1982, The Journal of antibiotics.
[28] Olga Genilloud,et al. Isolation, structure, and absolute stereochemistry of platensimycin, a broad spectrum antibiotic discovered using an antisense differential sensitivity strategy. , 2006, Journal of the American Chemical Society.
[29] O. White,et al. Global transposon mutagenesis and a minimal Mycoplasma genome. , 1999, Science.
[30] Jun Wang,et al. Platensimycin is a selective FabF inhibitor with potent antibiotic properties , 2006, Nature.
[31] D. Cully,et al. Discovery of a Small Molecule That Inhibits Cell Division by Blocking FtsZ, a Novel Therapeutic Target of Antibiotics* , 2003, Journal of Biological Chemistry.
[32] J. W. Campbell,et al. Bacterial fatty acid biosynthesis: targets for antibacterial drug discovery. , 2001, Annual review of microbiology.